Insider Shareholders with Direct Ownership of Mersana Therapeutics, Inc. (MRSN)
This section provides a comprehensive overview of the insiders with direct ownership of Mersana Therapeutics, Inc. (MRSN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Mersana Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
David M Mott
Director |
50,095 | 0 | 588,694 $1.18 Million | 5 |
Jan 02, 2024
Added 1.47%
|
Timothy B Lowinger
SVP, Chief Sci.&Tech. Officer |
305,278 | 105,949 | 199,329 $400,651 | 44 |
Jan 16, 2024
Reduced 4.96%
|
Anna Protopapas
Director |
315,976 | 334,131 | 125,153 $251,557 | 15 |
Jan 16, 2024
Reduced 19.02%
|
Brian De Schuytner
SVP, COO & CFO |
57,083 | 15,620 | 54,511 $109,567 | 10 |
Jan 16, 2024
Reduced 14.61%
|
Willard H Dere
Director |
39,182 | 0 | 39,182 $78,755 | 5 |
Jan 02, 2024
Added 13.49%
|
Michael J. Kaufman
Chief Manufacturing Officer |
46,667 | 14,045 | 32,622 $65,570 | 5 |
Jul 19, 2021
Reduced 16.21%
|
Arvin Yang
SVP, Chief Medical Officer |
44,084 | 13,263 | 30,821 $61,950 | 6 |
Jan 17, 2023
Reduced 6.69%
|
Alejandra Carvajal
SVP, Chief Legal Officer |
40,458 | 13,055 | 27,403 $55,080 | 9 |
Jan 16, 2024
Reduced 13.78%
|
Ashish Mandelia
VP, Chief Accounting Officer |
29,103 | 12,605 | 23,328 $46,889 | 14 |
Jan 16, 2024
Reduced 17.72%
|
Tushar Misra
SVP, Chief Manuf. Officer |
22,500 | 7,602 | 17,966 $36,111 | 9 |
Jan 16, 2024
Reduced 15.74%
|
Allene M. Diaz
Director |
14,467 | 0 | 14,467 $29,078 | 1 |
Jun 08, 2023
Added 50.0%
|
Lawrence M Alleva
Director |
14,467 | 0 | 14,467 $29,078 | 1 |
Jun 08, 2023
Added 50.0%
|
14,467 | 0 | 14,467 $29,078 | 1 |
Jun 08, 2023
Added 50.0%
|
|
Martin H. Huber Jr.
President, CEO |
14,467 | 0 | 14,467 $29,078 | 1 |
Jun 08, 2023
Added 50.0%
|
Kristen Hege
Director |
14,467 | 0 | 14,467 $29,078 | 1 |
Jun 08, 2023
Added 50.0%
|
Mohan Bala
SVP, Chief Development Officer |
15,000 | 5,343 | 14,052 $28,244 | 4 |
Jan 16, 2024
Reduced 19.62%
|